Circulating messenger RNA variants as a potential biomarker for surveillance of hepatocellular carcinoma

Circulating messenger RNA variants as a potential biomarker for surveillance of hepatocellular carcinoma

Background and rationaleLiver derived messenger ribonucleic acid (mRNA) transcripts were reported to be elevated in the circulation of hepatocellular carcinoma (HCC) patients. We now report the detection of high-risk mRNA variants exclusively in the circulation of HCC patients. Numerous genomic alle...

Full description

Bibliographic Details
Main Authors:	Timothy Block, Daniel Zezulinski, David E. Kaplan, Jingqiao Lu, Samantha Zanine, Tingting Zhan, Cataldo Doria, Aejaz Sayeed
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2022-12-01
Series:	Frontiers in Oncology
Subjects:	circulating mRNA variants hepatocellular carcinoma liver cirrhosis extracellular vesicles HCC surveillance and early detection
Online Access:	https://www.frontiersin.org/articles/10.3389/fonc.2022.963641/full

Similar Items

Diagnostic accuracy of ultrasound and alpha-fetoprotein measurement for hepatocellular carcinoma surveillance: a retrospective comparative study
by: Ahmed Haitham Abduljabbar
Published: (2023-02-01)

An Overview of Hepatocellular Carcinoma Surveillance Focusing on Non-Cirrhotic NAFLD Patients: A Challenge for Physicians
by: Annalisa Cespiati, et al.
Published: (2023-02-01)

Effect of Hepatocellular Carcinoma Surveillance Programmes on Overall Survival in a Mixed Cirrhotic UK Population: A Prospective, Longitudinal Cohort Study
by: Mohammad Inamul Haq, et al.
Published: (2021-06-01)

Surveillance for Hepatocellular Carcinoma in Patients with NASH
by: Philippe Kolly, et al.
Published: (2016-06-01)

MicroRNAs as Plasma Biomarkers of Hepatocellular Carcinoma in Patients with Liver Cirrhosis—A Cross-Sectional Study
by: Robin Zenlander, et al.
Published: (2024-02-01)

Hepatocellular carcinoma surveillance: Eastern and Western perspectives
by: Yvonne Purcell, et al.
Published: (2019-07-01)

Management of Hepatocellular Carcinoma in Decompensated Cirrhotic Patients: A Comprehensive Overview
by: Maria Tampaki, et al.
Published: (2023-02-01)

Diffuse infiltrative hepatocellular carcinoma or cirrhosis?
by: Jarosław Koza, et al.
Published: (2017-12-01)

Diffuse infiltrative hepatocellular carcinoma or cirrhosis?
by: Jarosław Koza, et al.
Published: (2017-12-01)

Adherence to Hepatocellular Carcinoma Surveillance and Perceived Barriers Among High-Risk Chronic Liver Disease Patients in Yunnan, China
by: Dai J, et al.
Published: (2020-07-01)

A Modified Protocol of Diethylnitrosamine Administration in Mice to Model Hepatocellular Carcinoma
by: Azra Memon, et al.
Published: (2020-07-01)

Persistent increase in alpha-fetoprotein level in a patient without underlying liver disease who underwent curative resection of hepatocellular carcinoma. A case report and review of the literature
by: Di Carlo Isidoro, et al.
Published: (2012-05-01)

Adaptive Subsets Limit the Anti-Tumoral NK-Cell Activity in Hepatocellular Carcinoma
by: Charlotte Rennert, et al.
Published: (2021-06-01)

Incidence and risk factors of early HCC occurrence in HCV patients treated with direct acting antivirals: a prospective multicentre study
by: Luca Rinaldi, et al.
Published: (2019-08-01)

High Rates of Liver Cirrhosis and Hepatocellular Carcinoma in Chronic Hepatitis B Patients with Metabolic and Cardiovascular Comorbidities
by: Jan-Hendrik Bockmann, et al.
Published: (2021-04-01)

Surveillance for hepatocellular carcinoma in patients with advanced liver fibrosis
by: Angelo Sangiovanni, et al.
Published: (2021-01-01)

Unawareness of hepatitis B infection and lack of surveillance are associated with severity of hepatocellular carcinoma
by: Kuan‐I Lee, et al.
Published: (2023-11-01)

Statin Use Decreases the Incidence of Hepatocellular Carcinoma: An Updated Meta-Analysis
by: Antonio Facciorusso, et al.
Published: (2020-04-01)

Genomic Relevance of <i>FGFR2</i> on the Prognosis of HCV-Induced Hepatocellular Carcinoma Patients
by: Walizeb Khan, et al.
Published: (2022-05-01)

The short-term efficacy of no-touch radiofrequency ablation in treating cirrhosis-based small hepatocellular carcinoma
by: Yuelong Chai, et al.
Published: (2019-05-01)

Long non-coding RNA HOTAIR and HOTTIP as potential biomarkers for hepatitis C virus genotype 4-induced hepatocellular carcinoma
by: Fawzy Roshdy, et al.
Published: (2020-02-01)

Circulating Cell-Free DNA Combined to Magnetic Resonance Imaging for Early Detection of HCC in Patients with Liver Cirrhosis
by: Marianna Alunni-Fabbroni, et al.
Published: (2021-01-01)

Comparable Overall Survival in Patients with Hepatocellular Carcinoma Diagnosed within and outside a Surveillance Programme: The Potential Impact of Liver Cirrhosis
by: Rosemary E. Faulkes, et al.
Published: (2023-02-01)

Possible diagnostic role of microRNA-122 in chronic HCV infection and hepatocellular carcinoma
by: Asmaa Thabet, et al.
Published: (2023-05-01)

Role of Fibroscan for early detection of hepatocellular carcinoma (HCC) in hepatitis C cirrhotic patients
by: Ahmed Elhosieny Ebrahim, et al.
Published: (2020-07-01)

Diagnostic performance of US LI-RADS in hepatocellular carcinoma surveillance
by: Ahmed Haitham Abduljabbar, et al.
Published: (2023-08-01)

Biological Predictors of De Novo Tumors in Solid Organ Transplanted Patients During Oncological Surveillance: Potential Role of Circulating TERT mRNA
by: Michela Cangemi, et al.
Published: (2021-10-01)

Prognostic significance of serum galectin-3 levels in patients with hepatocellular cancer and chronic viral hepatitis
by: Mehmet Ulu, et al.
Published: (2015-01-01)

Golgi Protein 73 versus Alpha-Fetoprotein as a New Biomarker in Early Diagnosis of Hepatocellular Carcinoma
by: Ali OM, et al.
Published: (2020-05-01)

ALBI grade: Evidence for an improved model for liver functional estimation in patients with hepatocellular carcinomaKey points
by: Coskun O. Demirtas, et al.
Published: (2021-10-01)

Diagnostic accuracy of serum protein induced by vitamin K absence (PIVKA‐II), serum a‐fetoprotein and their combination for hepatocellular carcinoma among Caucasian cirrhotic patients with diagnostic or non‐diagnostic serum a‐fetoprotein levels
by: Antonia Syriha, et al.
Published: (2024-02-01)

Serum level of hepcidin in cirrhotic patients as a marker for hepatocellular carcinoma
by: Khaled Mahmoud Mohiedeen, et al.
Published: (2024-02-01)

A Novel Pathological Scoring System for Hepatic Cirrhosis with Hepatocellular Carcinoma
by: Dong W, et al.
Published: (2020-07-01)

Discovery of plasma messenger RNA as novel biomarker for gastric cancer identified through bioinformatics analysis and clinical validation
by: Wei Cao, et al.
Published: (2019-06-01)

Risk of Liver Cirrhosis and Hepatocellular Carcinoma after Fontan Operation: A Need for Surveillance
by: Jun Sik Yoon, et al.
Published: (2020-07-01)

Lipid nanoparticles that deliver IL-12 messenger RNA suppress tumorigenesis in MYC oncogene-driven hepatocellular carcinoma
by: Ian Lai, et al.
Published: (2018-11-01)

Alternative Splicing in Hepatocellular CarcinomaSummary
by: Seung Eun Lee, et al.
Published: (2020-01-01)

PHARMACOLOGICAL THERAPY OF HEPATOCELLULAR CANCER PRACTICAL ISSUES AND SOLUTIONS
by: V. V. Breder, et al.
Published: (2017-11-01)

Characterization of proteins, mRNAs, and miRNAs of circulating extracellular vesicles from prostate cancer patients compared to healthy subjects
by: Jolene Chisholm, et al.
Published: (2022-12-01)

HCC or Something Else? Frequency of Various Benign and Malignant Etiologies in Cirrhotic Patients with Newly Detected Focal Liver Lesions in Relation to Different Clinical and Sonographic Parameters
by: Amjad Alhyari, et al.
Published: (2022-08-01)